William D. Kerns

Dr. Kerns has over 20 years of experience in Pharmaceutical Research and Development at SmithKline Beecham and Eisai Pharmaceuticals. As a Senior Executive he has participated in the development of drugs for over 100 Phase I studies and 13 NDAs/MAAs. Bill has chaired a FDA committee on biomarkers and he is an expert in preclinical development and regulatory strategy.